Audit Report

Novacyl JA – 785

Audit #: JA - 785
Region: France
Material: API/Excipients
Company: Novacyl
Location: Rue Gaston Monmousseau 38150 Rousillon, France
Date: 3-4 May 2017

This Rx-360 Audit Report contains the following scope:

The scope of the audit was focused on the main processes of manufacturing, packaging,
labeling, testing and controls and warehousing of Salicylic Acid and Methyl Salicylate.
The audit was based on Rx-360 Audit standards for Active Pharmaceutical Ingredients
(APIs) and API Intermediates and included a supply chain security component based on the
Rx-360 Consortium Supply Chain Security Checklist.